Previous studies have shown that SLAMF6 expression is associated with improved progression-free and overall survival in breast cancer and melanoma, in which SLAMF6+ CD8+ T cells maintain the ability of multifunctionality and contribute to long-term tumor control [84]. Here, SLAMF6 is linked to breast cancer.